02Dec

Manage Waste Medicines & Ensure Compliance  

 

Now available from Alpha Laboratories is the Safer Options range of Controlled Drug Denature Kits which can help you safely manage waste medicines and comply with legislation more easily and effectively. 
 
Manufactured in the UK, these denature kits are simple and easy to use. Waste medicines – tablets, liquids, patches etc. are placed in the jar with the water-soluble sachet of denaturing formula. Water is then added to the designated level and the jar closed and shaken to mix the denaturing formula with the water and controlled drugs.
 
The denaturing formula congeals and denatures the drugs in a couple of minutes and the kit can then be placed in a secure pharmaceutical waste container prior to incineration. The denaturing formula has a bitter taste as an additional deterrent and is contained in a sachet to protect against spillage.  Full instructions appear on every container so there is no pack insert to get lost, especially when splitting up multipacks for use in separate locations.
 
Under the Misuse of Drugs Regulations (2001) obsolete controlled drugs (CDs) must be destroyed by being denatured and rendered irretrievable before being placed into pharmaceutical waste containers.  These new controlled drugs denature kits are an innovative and unique solution helping hospitals, pharmacies, hospices, care homes and other healthcare providers to safely manage waste medicines and comply with this legislation. 
 
The kits are available in six container volumes and a range of pack sizes providing multiple options to suit your working needs.
 
Please visit www.alphalabs.co.uk/denaturekits for further information or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk  

Related

Entrust People and SCI Search & Selection rebrand to Entrust Resource Solutions

Following a year of strong growth and successful acquisitions, Entrust People and SCI Search & Selec...

Read More >

Invasive Aspergillosis Screening in COVID-19 & Critical Care Patients

IMMY sõna Aspergillus Galactomannan Lateral Flow Assay recommended by the European Confederation of ...

Read More >

Diabetes Research Unit Cymru confirms EKF POCT HbA1c testing comparable to lab-based HPLC

Cardiff, UK – 21st June 2017 – EKF Diagnostics, the global in vitro diagnostics company, announces...

Read More >

SpeeDx receives CE-IVD mark for multiplex PlexPCR® VHS test for VZV, herpes and syphilis

SYDNEY, AUSTRALIA–(October 25, 2017). SpeeDx Pty. Ltd. has announced that it has received CE-IVD ma...

Read More >

EKF Diagnostics opens new R&D facility in UK

Special Projects Laboratory opened in EKF’s Cardiff HQ to develop new applications in non-core mark...

Read More >